Clinical utility of hepatitis B surface antigen kinetics in treatment-na ïve chronic hepatitis B patients during long-term entecavir therapy.

CONCLUSION: Baseline HBsAg can be used to predict treatment responses. HBsAg levels and decrease rates should be considered together according to disease status while interpreting HBsAg changes. PMID: 29456411 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29456411?dopt=Abstract

Source: World Journal of Gastroenterology : WJG - February 14, 2018 Category: Gastroenterology Authors: Lin TC, Chiu YC, Chiu HC, Liu WC, Cheng PN, Chen CY, Chang TT, Wu IC Tags: World J Gastroenterol Source Type: research